Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases. | Pharmaceutics | 2023 | 37514191 | PubTator, text mining | PubMed |
| Exosomes as an Emerging Plasmid Delivery Vehicle for Gene Therapy. | Pharmaceutics | 2023 | 37514019 | PubTator, text mining | PubMed |
| Prevention and Treatment of Retinal Vein Occlusion: The Role of Diet-A Review. | Nutrients | 2023 | 37513655 | PubTator, text mining | PubMed |
| The Ratio of cf-mtDNA vs. cf-nDNA in the Follicular Fluid of Women Undergoing IVF Is Positively Correlated with Age. | Genes (Basel) | 2023 | 37510407 | PubTator, text mining | PubMed |
| Progressive Cone-Rod Dystrophy and RPE Dysfunction in Mitfmi/+ Mice. | Genes (Basel) | 2023 | 37510362 | PubTator, text mining | PubMed |
| A Description of the Yield of Genetic Reinvestigation in Patients with Inherited Retinal Dystrophies and Previous Inconclusive Genetic Testing. | Genes (Basel) | 2023 | 37510321 | PubTator, text mining | PubMed |
| Pearls and Pitfalls of Adaptive Optics Ophthalmoscopy in Inherited Retinal Diseases. | Diagnostics (Basel) | 2023 | 37510157 | PubTator, text mining | PubMed |
| Clinically actionable secondary findings in 130 triads from sub-Saharan African families with non-syndromic orofacial clefts. | Mol Genet Genomic Med | 2023 | 37496383 | PubTator, text mining | PubMed |
| Interferon alpha and beta receptor 1 knockout in human embryonic kidney 293 cells enhances the production efficiency of proteins or adenoviral vectors related to type I interferons. | Front Bioeng Biotechnol | 2023 | 37476482 | PubTator, text mining | PubMed |
| Usher Syndrome on the Island of Ireland: A Genotype-Phenotype Review. | Invest Ophthalmol Vis Sci | 2023 | 37466950 | PubTator, text mining | PubMed |
Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures. | J Patient Rep Outcomes | 2023 | 37466759 | PubTator, text mining | PubMed |
| Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model. | Transl Vis Sci Technol | 2023 | 37462980 | PubTator, text mining | PubMed |
| Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery. | Stem Cells Transl Med | 2023 | 37459045 | PubTator, text mining | PubMed |
| A short story on how chromophore is hydrolyzed from rhodopsin for recycling. | Bioessays | 2023 | 37454357 | PubTator, text mining | PubMed |
| Retinal Prostheses: Engineering and Clinical Perspectives for Vision Restoration. | Sensors (Basel) | 2023 | 37447632 | PubTator, text mining | PubMed |
| Clinical Characteristics and Genetic Variants of a Large Cohort of Patients with Retinitis Pigmentosa Using Multimodal Imaging and Next Generation Sequencing. | Int J Mol Sci | 2023 | 37446072 | PubTator, text mining | PubMed |
| Clinical and Molecular Aspects of C2orf71/PCARE in Retinal Diseases. | Int J Mol Sci | 2023 | 37445847 | PubTator, text mining | PubMed |
| The Role of Subretinal Injection in Ophthalmic Surgery: Therapeutic Agent Delivery and Other Indications. | Int J Mol Sci | 2023 | 37445711 | PubTator, text mining | PubMed |
| Role of Chondroitin Sulfate Proteoglycan 5 in Steroid-Induced Cataract. | Cells | 2023 | 37443739 | PubTator, text mining | PubMed |
| Aberrant Akt2 signaling in the RPE may contribute to retinal fibrosis process in diabetic retinopathy. | Cell Death Discov | 2023 | 37443129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=17